Cancer discovery, 2020-02, Vol.10 (2), p.232-253
2020
Details
- Autor(en) / Beteiligte
- Titel
- Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15 + Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
- Ist Teil von
- Cancer discovery, 2020-02, Vol.10 (2), p.232-253
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- With only a fraction of patients responding to cancer immunotherapy, a better understanding of the entire tumor microenvironment is needed. Using single-cell transcriptomics, we chart the fibroblastic landscape during pancreatic ductal adenocarcinoma (PDAC) progression in animal models. We identify a population of carcinoma-associated fibroblasts (CAF) that are programmed by TGFβ and express the leucine-rich repeat containing 15 (LRRC15) protein. These LRRC15 CAFs surround tumor islets and are absent from normal pancreatic tissue. The presence of LRRC15 CAFs in human patients was confirmed in >80,000 single cells from 22 patients with PDAC as well as by using IHC on samples from 70 patients. Furthermore, immunotherapy clinical trials comprising more than 600 patients across six cancer types revealed elevated levels of the LRRC15 CAF signature correlated with poor response to anti-PD-L1 therapy. This work has important implications for targeting nonimmune elements of the tumor microenvironment to boost responses of patients with cancer to immune checkpoint blockade therapy. SIGNIFICANCE: This study describes the single-cell landscape of CAFs in pancreatic cancer during tumor evolution. A TGFβ-driven, LRRC15 CAF lineage is associated with poor outcome in immunotherapy trial data comprising multiple solid-tumor entities and represents a target for combinatorial therapy. .
- Sprache
- Englisch
- Identifikatoren
- ISSN: 2159-8274eISSN: 2159-8290DOI: 10.1158/2159-8290.CD-19-0644Titel-ID: cdi_crossref_primary_10_1158_2159_8290_CD_19_0644
- Format
- –
- Schlagworte
- Animals, B7-H1 Antigen - antagonists & inhibitors, B7-H1 Antigen - immunology, Cancer-Associated Fibroblasts - drug effects, Cancer-Associated Fibroblasts - immunology, Cancer-Associated Fibroblasts - metabolism, Carcinoma, Pancreatic Ductal - drug therapy, Carcinoma, Pancreatic Ductal - genetics, Carcinoma, Pancreatic Ductal - immunology, Cell Line, Tumor, Cell Lineage - genetics, Cell Lineage - immunology, Clinical Trials as Topic, Computational Biology, Disease Models, Animal, Drug Resistance, Neoplasm - drug effects, Drug Resistance, Neoplasm - genetics, Drug Resistance, Neoplasm - immunology, Gene Expression Regulation, Neoplastic - drug effects, Gene Expression Regulation, Neoplastic - immunology, Humans, Immune Checkpoint Inhibitors - pharmacology, Immune Checkpoint Inhibitors - therapeutic use, Membrane Proteins - metabolism, Mice, Myofibroblasts - drug effects, Myofibroblasts - immunology, Myofibroblasts - metabolism, Pancreatic Neoplasms - drug therapy, Pancreatic Neoplasms - genetics, Pancreatic Neoplasms - immunology, RNA-Seq, Single-Cell Analysis, Transforming Growth Factor beta - metabolism, Treatment Outcome, Tumor Microenvironment - drug effects, Tumor Microenvironment - genetics, Tumor Microenvironment - immunology